Shopping Cart
Remove All
Your shopping cart is currently empty
LOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM)

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $43 | In Stock | In Stock | |
| 10 mg | $81 | In Stock | In Stock | |
| 25 mg | $171 | In Stock | In Stock | |
| 50 mg | $310 | In Stock | In Stock | |
| 100 mg | $543 | In Stock | In Stock |
| Description | LOC14 to be the most potent PDI inhibitor reported to date( EC50 : 500 nM) |
| Targets&IC50 | PDI:500 nM(EC50) |
| In vitro | LOC14-induced oxidation of PDI has a neuroprotective effect not only in cell culture, but also in corticostriatal brain slice cultures[1]. |
| In vivo | LOC14 showed high stability in liver microsomes and blood plasma, was tolerated at a high dose of 20 mg/kg in mice, and penetrated the BBB in vivo[1][2]. |
| Animal Research | LOC14 levels were measured in mouse plasma, striatum and cerebral cortex using Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).?LOC14 was extracted from mouse plasma by mixing 100 μl of plasma with 900 μl of cold acetonitrile containing 25 ng/ml of cyclocreatine as an internal standard.?After mixing for 5 min. the sample was centrifuged for 10min and the organic layer was transferred to an LC-MS vial and dried under nitrogen.?The sample was reconstituted in 100 μl of 50% acetonitrile and 5 μl was injected onto the LC-MS.?Brain tissue samples were homogenized using a tissue tearor at a concentration of 150 mg/ml in cold LC-MS water followed by extraction with 1.8 ml of cold acetonitrile containing the cyclocreatine internal standard.?The brain samples were mixed and centrifuged and reconstituted the same as for the plasma samples[2]. |
| Molecular Weight | 317.41 |
| Formula | C16H19N3O2S |
| Cas No. | 877963-94-5 |
| Smiles | O=C(C1CC1)N1CCN(Cn2sc3ccccc3c2=O)CC1 |
| Relative Density. | 1.390 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (157.52 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.3 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.